Using SCIEX Triple Quad™ 7500 LC-MS/MS System – QTRAP® Ready, powered by SCIEX OS Software
Ian Moore1 and Lei Xiong2
1SCIEX, Canada: 2SCIEX, USA
Host cell proteins (HCPs) are process-related impurities monitored in downstream biotherapeutic manufacturing and QC, requiring highly sensitive and robust assays. Here, the simultaneous quantification of 48 proteins in an HCP-like sample was demonstrated using the SCIEX Triple Quad™ 7500 LC-MS/MS System, with an 8 min LC-MS analysis, and LLOQs ranging from 0.02 to 4.54 ppm.
Host cell proteins (HCPs) are a major class of process-related impurities that accompany a recombinant biotherapeutic product during production. As their levels impact the potential toxicity and efficiency of the therapeutics, there are significant requirements for the quantitative measurement of HCP’s across the entire development paradigm, from discovery to quality control.
In downstream manufacturing and QC stages, the HCP targets for quantification are typically predefined, and their levels in the final drug substance or late purification steps can be at the trace level. This results in the increased need for targeted HCP analysis methods with high sensitivity, reduced analysis time, robustness and multiplexing capability (quantify significant numbers of analytes in one injection). Triple quadrupole and QTRAP LC-MS/MS Systems are ideal instrument platforms for such work due to their high quantitative performance.
Herein, a targeted HCP analysis workflow utilizing the SCIEX Triple Quad 7500 LC-MS/MS System – QTRAP Ready has been developed. Multiple hardware improvements on the ion source and the front end of the mass analyzer significantly boost the instrument sensitivity.1
The Scheduled MRMTM Algorithm2 was used to enable the simultaneous quantification of 48 proteins (4 transitions per protein) in an 8 min LC-MS analysis, with LLOQs ranging from 0.02 to 4.54 ppm.
Sample preparation: NISTmAb monoclonal antibody (NISTmAb) and the Universal Proteomics Standard (UPS) were purchased from Sigma-Aldrich. In this experiment model, NISTmAb was serving as the biotherapeutic molecule, while the 48 human proteins in the UPS mix were used to mimic the targeted HCPs for quantification. Bovine serum albumin (BSA) was used as the internal standard. The UPS proteins and BSA were spiked into NISTmAb solution to prepare high concentration standard sample. It was then serial diluted using the NISTmAb solution with BSA. The levels of NISTmAb and BSA remains consistent among all samples.3
Samples were denatured by incubating with N-octyl-glucoside (OGS), reduced by dithiothreitol (DTT) and alkylated by iodoacetamide (IAM). A trypsin/Lys-C digestion was performed at 37 °C overnight, with an enzyme-protein ratio at 1:25. Formic acid was spiked into the samples to abort digestion. The samples were then centrifuged at the speed of 12000 g and injected into LC-MS analysis.
LC-MS conditions: Samples were analyzed in triplicate by a SCIEX Triple Quad 7500 LC-MS/MS System – QTRAP Ready, coupled with an ExionLC™ System. The method details are summarized in Table 1, 2 and Table A1. The same sample set was also analyzed using a SCIEX Triple Quad 6500+ LC-MS/MS System, coupled with the same HPLC system, to compare the performance of the two mass spectrometers. All MRM parameters were optimized on both mass spectrometers for the most accurate performance comparison.
Data processing: Data are processed using the Analytics function in SCIEX OS Software 2.0.
The signature peptide selection and MRM method development process are reported in a previous technical note.1 An IDA analysis was performed on a TripleTOF® 6600+ LC-MS/MS System to analyze the digested NISTmAb-UPS protein mix. The IDA data was processed by ProteinPilot™ Software 5.0, searched against the protein sequences of NISTmAb, UPS proteins and BSA. The database search result file (serving as the peptide library) and protein sequences were then imported into Skyline software. The list of MRM transitions was generated based on peptide/transitions settings and peptide library matching.
The list of MRM transitions was then imported into SCIEX OS Software and test injections were performed to determined the retention times of each peptide using the fast 8-min gradient (Figure 2). Retention times were then uploaded to the Scheduled MRM Algorithm and the optimized method was computed, maximizing dwell times for every MRM. This time scheduled method was used to acquire all the calibration curve data.
Improvements to the ion generation and sampling have led to increased sensitivity on the SCIEX 7500 System. To characterize the impact on host cell protein quantification workflows, the UPS protein serial dilution samples were analyzed on both the SCIEX 7500 System and the SCIEX Triple Quad 6500+ LC-MS/MS System. On average, a 4-fold difference in S/N was observed (Figure 3).
Holding the amount of NISTmAb constant per injection at 20 µg, the LLOQs for the UPS proteins (the HCPs) were reported in the format of ppm. All 48 proteins were quantified using 2 peptides per protein for most proteins and 2 transitions per peptide (Figure 3) for confidence in detection and quantification. The LLOQs determined ranged from 0.02 ppm to 4.54 ppm, with 2/3 of them between 0.02 and 1 ppm. The rest were between 1 and 4.54 ppm (Figure 4). Accuracies of all peptides are 85-115% and the %CV are within 15%. Representative XICs of UPS proteins at their LLOQ levels, calibration curves, and quantification results are shown in Figures 1, 4 and 5.